Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Lihong LiuDavid D Ho


The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic continues, with devasting consequences for human lives and the global economy1,2. The discovery and development of virus-neutralizing monoclonal antibodies could be one approach to treat or prevent infection by this coronavirus. Here we report the isolation of sixty-one SARS-CoV-2-neutralizing monoclonal antibodies from five patients infected with SARS-CoV-2 and admitted to hospital with severe coronavirus disease 2019 (COVID-19). Among these are nineteen antibodies that potently neutralized authentic SARS-CoV-2 in vitro, nine of which exhibited very high potency, with 50% virus-inhibitory concentrations of 0.7 to 9 ng ml-1. Epitope mapping showed that this collection of nineteen antibodies was about equally divided between those directed against the receptor-binding domain (RBD) and those directed against the N-terminal domain (NTD), indicating that both of these regions at the top of the viral spike are immunogenic. In addition, two other powerful neutralizing antibodies recognized quaternary epitopes that overlap with the domains at the top of the spike. Cryo-electron microscopy reconstructions of one antibody that targets the RBD, a second that target...Continue Reading


Sep 1, 1997·Nucleic Acids Research·S F AltschulD J Lipman
Dec 4, 2003·Journal of Synchrotron Radiation·Paul D AdamsThomas C Terwilliger
Jun 25, 2004·Nucleic Acids Research·Ian W DavisDavid C Richardson
Jul 21, 2004·Journal of Computational Chemistry·Eric F PettersenThomas E Ferrin
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
May 14, 2005·Journal of Structural Biology·Christian SulowayBridget Carragher
Nov 4, 2008·Nucleic Acids Research·Marie-Paule LefrancPatrice Duroux
Aug 17, 2010·Bioinformatics·Robert C Edgar
Oct 31, 2013·Methods in Molecular Biology·Fabian Sievers, Desmond G Higgins
Aug 19, 2015·Nature Methods·Benjamin A BaradJames S Fraser
Feb 7, 2017·Nature Methods·Ali PunjaniMarcus A Brubaker
Jul 16, 2017·Protein Science : a Publication of the Protein Society·Thomas D GoddardThomas E Ferrin
Jun 7, 2018·Acta Crystallographica. Section D, Structural Biology·Tristan Ian Croll
Jan 28, 2020·Lancet·Chen WangGeorge F Gao
Feb 23, 2020·Science·Daniel WrappJason S McLellan
Mar 11, 2020·Cell·Alexandra C WallsDavid Veesler
Mar 25, 2020·Emerging Microbes & Infections·Jianhui NieYouchun Wang
Mar 28, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jasper Fuk-Woo ChanKwok-Yung Yuen
May 6, 2020·Nature Communications·Chunyan WangBerend-Jan Bosch
Jun 20, 2020·Nature·Davide F RobbianiMichel C Nussenzweig

❮ Previous
Next ❯


Aug 26, 2020·Pathogens and Disease·Jitendra Singh Rathore, Chaitali Ghosh
Sep 18, 2020·Expert Opinion on Therapeutic Targets·Shibo JiangLanying Du
Sep 24, 2020·Nature·Florian Krammer
Oct 2, 2020·Current Opinion in HIV and AIDS·Ivan F N Hung
Aug 26, 2020·Nature Reviews. Immunology·Rebecca J Cox, Karl A Brokstad
Oct 6, 2020·Frontiers in Immunology·Maria TrovatoPiergiuseppe De Berardinis
Aug 7, 2020·International Journal of Molecular Sciences·Sareh ZhandMark W Douglas
Sep 21, 2020·Signal Transduction and Targeted Therapy·Yeping SunJianxun Qi
Sep 24, 2020·Signal Transduction and Targeted Therapy·Fei YuShibo Jiang
Aug 26, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kelvin Kai-Wang ToKwok-Yung Yuen
Sep 24, 2020·Journal of Medical Virology·Matías J PeresonFederico A Di Lello
Oct 13, 2020·Nature·Christopher O BarnesPamela J Bjorkman
Oct 20, 2020·Journal of Medical Virology·Charles W StrattonHongzhou Lu
Nov 20, 2020·The Journal of Experimental Medicine·Alexandra SchäferTimothy P Sheahan
Oct 29, 2020·ELife·Yiska WeisblumPaul D Bieniasz
Nov 25, 2020·Current Opinion in HIV and AIDS·Pilar MendozaChristian Gaebler
Dec 9, 2020·Science Translational Medicine·Zijun WangMichel C Nussenzweig
Dec 10, 2020·Nature Biomedical Engineering·Shibo JiangLanying Du
Dec 16, 2020·Lab on a Chip·Roberto Rodriguez-MoncayoJose L Garcia-Cordero
Dec 16, 2020·SLAS Discovery·Dawid MaciorowskiAdinarayana Kunamneni
Dec 22, 2020·Population Health Management·Maren S FragalaSteven E Goldberg
Aug 14, 2020·The Journal of Cell Biology·Fred D MastJohn D Aitchison
Dec 29, 2020·Advanced Drug Delivery Reviews·Jee Young ChungYoung Jik Kwon
Jan 5, 2021·Frontiers in Immunology·Yannick GalipeauMarc-André Langlois
Jan 1, 2021·Trends in Cardiovascular Medicine·Shereif H Rezkalla, Robert A Kloner
Jan 9, 2021·Journal of Biomolecular Structure & Dynamics·M Elizabeth SobhiaHarmanpreet Singh
Jan 14, 2021·The Biochemical Journal·George M Burslem
Dec 12, 2020·Cell Host & Microbe·Drew WeissmanDavid C Montefiori
Oct 25, 2020·The Protein Journal·Mihaela Ileana Ionescu
Jan 12, 2021·The Journal of Biological Chemistry·Sameer Kumar MalladiRaghavan Varadarajan
Sep 30, 2020·Cytotherapy·Kuttuvan Valappil Sajna, Siya Kamat

❮ Previous
Next ❯

Datasets Mentioned


Methods Mentioned

flow cytometry
enzyme-linked immunosorbent assays

Key Resources (RRID) Mentioned


Software Mentioned

GraphPad Prism
UCSF Chimera

Related Concepts

Related Feeds